IPSC - Century Therapeutics GAAP EPS of -$0.66 misses by $0.20 revenue of $1.06M misses by $5.61M
Century Therapeutics press release (NASDAQ:IPSC): Q1 GAAP EPS of -$0.66 misses by $0.20. Revenue of $1.06M misses by $5.61M. Cash, cash equivalents, and investments were $466.4 million as of March 31, 2022, as compared to $358.8 million as of December 31, 2021.
For further details see:
Century Therapeutics GAAP EPS of -$0.66 misses by $0.20, revenue of $1.06M misses by $5.61M